Smoking cessation

Global Amino Acids Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, February 4, 2022

What has been the impact of COVID-19 on the global amino acids market?

Key Points: 
  • What has been the impact of COVID-19 on the global amino acids market?
  • What are the various stages in the value chain of the global amino acids market?
  • What are the key driving factors and challenges in the global amino acids market?
  • What is the structure of the global amino acids market and who are the key players?

Global Corporate Wellness Markets, 2021-2030 - Promotion of Mental Well-Being at Workplaces, Growing Reign of Artificial Intelligence (Ai), & Extension of Wellness Programs To Family

Retrieved on: 
Friday, January 28, 2022

Additionally, the growing awareness about health and wellbeing among the youth is also expected to propel the corporate wellness market to new heights.

Key Points: 
  • Additionally, the growing awareness about health and wellbeing among the youth is also expected to propel the corporate wellness market to new heights.
  • When end-user is taken into consideration, the corporate wellness market is categorized into large-scale organizations, medium-scale organizations, and small-scale organizations.
  • Owing to their larger workforces, these companies are compelled to implement corporate wellness programs.
  • Moreover, these companies are secure and strong financially and thus, they can easily make huge investments in corporate wellness programs.

Corporate Wellness Market Report 2021 - Global Industry Revenue Estimation Demand Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 27, 2022

The "Corporate Wellness Market Research Report - Global Industry Revenue Estimation Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Corporate Wellness Market Research Report - Global Industry Revenue Estimation Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global corporate wellness market revenue stood at $51 billion in 2020, and it is expected to rise to $100 billion by 2030
    The market will progress at a CAGR of 7.0% from 2020 to 2030 (forecast period).
  • Additionally, the growing awareness about health and wellbeing among the youth is also expected to propel the corporate wellness market to new heights.
  • When end-user is taken into consideration, the corporate wellness market is categorized into large-scale organizations, medium-scale organizations, and small-scale organizations.

Respira Technologies, Inc. announces Jasjit S. Ahluwalia, MD, MPH, MS as Chair of the company's newly formed Scientific Advisory Board.

Retrieved on: 
Tuesday, January 18, 2022

LOS ANGELES, Calif., Jan. 18, 2022 /PRNewswire/ -- Respira Technologies, Inc. (Los Angeles, CA) announced today, the formation of its Scientific Advisory Board and named Dr. Jasjit ("Jas") S. Ahluwalia as Chair of the newly formed advisory board.

Key Points: 
  • LOS ANGELES, Calif., Jan. 18, 2022 /PRNewswire/ -- Respira Technologies, Inc. (Los Angeles, CA) announced today, the formation of its Scientific Advisory Board and named Dr. Jasjit ("Jas") S. Ahluwalia as Chair of the newly formed advisory board.
  • Danek added, "We are thrilled to name Dr. Ahluwalia as Chair and the founding member of our Scientific Advisory Board.
  • He represents one of the best and brightest scientific minds with decades of experience in studying nicotine addiction and cessation.
  • Respira is backed by venture firms: Blue Ledge Capital, Compass Rose, DG Ventures, Evolution VC Partners and Poseidon Asset Management.

Sana Joins Forces With Proactive MD to Open Sana MD, a First-of-its-Kind Advanced Primary Care Health Center for Small and Midsize Businesses

Retrieved on: 
Wednesday, January 12, 2022

Sana , a value-based health care company that provides Fortune 500-level health care to small businesses at affordable prices, and Proactive MD , a leader in advanced primary care, today announced that their first joint primary care health center, Sana MD, will open on Jan. 24.

Key Points: 
  • Sana , a value-based health care company that provides Fortune 500-level health care to small businesses at affordable prices, and Proactive MD , a leader in advanced primary care, today announced that their first joint primary care health center, Sana MD, will open on Jan. 24.
  • View the full release here: https://www.businesswire.com/news/home/20220112005110/en/
    Sana Joins Forces With Proactive MD to Open Sana MD, a First-of-its-Kind Advanced Primary Care Health Center for Small and Midsize Businesses (Photo: Business Wire)
    The health center is located at 1715 W. 35th St. in Austin, Texas.
  • Sana MD meets the needs of small and medium-sized businesses, providing better and more affordable care options for employees.
  • Adding Sana MD to our Sana Care ecosystem of providers will enable us to empower members to take control of their health with unrivaled primary care at no cost, said Sana CEO and co-founder Will Young.

Spero Health Brings Addiction Treatment Services to New States in 2022: West Virginia and North Carolina

Retrieved on: 
Tuesday, December 28, 2021

More people in West Virginia and North Carolina died of drug overdoses in 2020 than in any previous year on record, according to local medical data.

Key Points: 
  • More people in West Virginia and North Carolina died of drug overdoses in 2020 than in any previous year on record, according to local medical data.
  • This new data underscores how urgent and critical the need is in all communities across the United States.
  • In 2021, Spero Health earned a Net Promoter Score (NPS) of 82.1 among patients in their outpatient addiction treatment program.
  • This integrated care model combines physician services (including medication-assisted treatment), behavioral health counseling, recovery support services, medication management and patient and family education.

Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted Treatments

Retrieved on: 
Wednesday, December 22, 2021

Together, the two companies plan to co-develop a novel digital therapeutics (DTx) platform.

Key Points: 
  • Together, the two companies plan to co-develop a novel digital therapeutics (DTx) platform.
  • This collaborative partnership aims to enhance Mindleaps digital platform by collecting and computing unique data to create more personalized treatments for patients.
  • Once the new DTx platform is complete, physicians could prescribe the new digital therapeutic in addition to Mydecines drug and therapy protocols or as a standalone option.
  • This developing partnership with Maya will enable both companies to create standalone evidence-based software as a medical device DTx platform.

Worldwide Smoking Cessation & Nicotine De-Addiction Product Industry to 2026 - Development and Increasing Approvals of New Nicotine Replacement Products Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 15, 2021

Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smoking Cessation & Nicotine De-Addiction Product Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
  • What is the competitive strategic window for opportunities in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
  • What is the market share of the leading vendors in the Global Smoking Cessation & Nicotine De-Addiction Product Market?
  • What modes and strategic moves are considered suitable for entering the Global Smoking Cessation & Nicotine De-Addiction Product Market?

Digital Therapeutics Market to Reach $23.56 Billion, Globally, by 2030 at 20.6% CAGR: Allied Market Research

Retrieved on: 
Monday, December 6, 2021

On the other hand, lack of awareness regarding digital therapeutics in developing countries restrains the growth to some extent.

Key Points: 
  • On the other hand, lack of awareness regarding digital therapeutics in developing countries restrains the growth to some extent.
  • Rise of digital health impacted the global digital therapeutics market positively.
  • On the basis of application, the diabetes segment held the major share in 2020, garnering nearly one-fourth of the global digital therapeutics market.
  • On the basis of product type, the software segment contributed to the lion's share in 2020, holding more than two-thirds of the global digital therapeutics market.

Digital Therapeutics Market to Reach $23.56 Billion, Globally, by 2030 at 20.6% CAGR: Allied Market Research

Retrieved on: 
Monday, December 6, 2021

PORTLAND, Ore., Dec. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Digital Therapeutics Market by Application (Diabetes, Obesity, Cardio Vascular Diseases (CVD), Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders, and Others), Product Type (Software, and Devices), and Sales Channel (Business-to-Business and Business-to-Consumers): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global digital therapeutics industry was estimated at $3.53 billion in 2020, and is anticipated to hit $23.56 billion by 2030, registering a CAGR of 20.6% from 2021 to 2028.

Key Points: 
  • On the other hand, lack of awareness regarding digital therapeutics in developing countries restrains the growth to some extent.
  • Rise of digital health impacted the global digital therapeutics market positively.
  • On the basis of application, the diabetes segment held the major share in 2020, garnering nearly one-fourth of the global digital therapeutics market.
  • On the basis of product type, the software segment contributed to the lion's share in 2020, holding more than two-thirds of the global digital therapeutics market.